Physician profile
John T Lehr
NPI 1447211289
$59,707.20
in general payments reported to CMS, 2019-2025
24 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,382 · 2020: $241 · 2021: $387 · 2022: $18K · 2023: $34K · 2024: $156 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Food and Beverage: $1,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,990.00 |
| Food and Beverage | $1,218.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $51,075.00 | 2022-2023 | Hillrom - Retinavue Network, Hillrom - Retinavue 700 Imager |
| Welch Allyn | $6,210.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $418.14 | 2019-2025 | Eylea, Eylea Hd |
| Abbvie INC. | $313.25 | 2022-2025 | |
| Alimera Sciences, INC. | $179.59 | 2019-2023 | Iluvien |
| Alcon Vision LLC | $150.75 | 2023 | Clareon |
| Astellas Pharma US INC | $142.85 | 2023-2025 | Izervay |
| Bausch & Lomb Americas INC. | $142.16 | 2022-2024 | Xipere |
| Novartis Pharmaceuticals Corporation | $140.82 | 2019-2021 | |
| Rxsight INC | $138.55 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Allergan, INC. | $122.62 | 2019-2021 | |
| Regeneron Pharmaceuticals, INC. | $112.85 | 2020 | |
| Genentech USA, INC. | $109.23 | 2021-2023 | Vabysmo |
| Sun Pharmaceutical Industries INC. | $80.76 | 2019-2020 | |
| Apellis Pharmaceuticals, INC. | $67.10 | 2023-2025 | Syfovre |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $52.54 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Johnson & Johnson Surgical Vision, INC. | $50.56 | 2021-2023 | Tecnis Iol |
| Kala Pharmaceuticals, INC. | $43.25 | 2021 | |
| Oculus Surgical INC. | $36.83 | 2022 | |
| Eyepoint US, INC. | $34.41 | 2021 | |
| Mallinckrodt Hospital Products INC. | $33.75 | 2022 | |
| Coherus Oncology, INC. | $18.94 | 2022 | |
| Ocular Therapeutix, INC. | $16.91 | 2025 | Dextenza |
| Ani Pharmaceuticals, INC. | $16.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lehr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.